Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-006530
Date:2020-05-20
Issuer: THERAVANCE BIOPHARMA, INC. (TBPH)
Original Submission Date:

Reporting Person:

SABESAN VIJAY
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2020-05-20 F 3,801 d $26.67 200,641 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 includes 1,402 shares acquired under the theravance biopharma, inc. 2013 employee share purchase plan on may 15, 2020.
WhaleWisdom Logo

Elevate your investments